D6Y-94039-26820
2 vaccinations
5 coded responses
18 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 492 / MI
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Moderna
-
2021-03-19
Survey response — day 0, dose 1MedDRA: Bradykinesia, Dizziness, Slow speech — Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to workFree text: Light headed and feeling like I'm speaking and moving slowlyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-03-26
Health check-in — day 7, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-04
Survey response — day 14, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Body aches, headaches, chills, injectionsite soreness, worsening pre-existing autoimmune symptoms (fibromyalgia, alopecia, migratory glossidis)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
-
2021-04-15
Dose 2 — Moderna
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-20
- 2021-04-21
-
2021-04-22
Health check-in — day 7, dose 2Feeling: Good · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-29
-
2021-05-06
Survey response — day 21, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Underlying autoimmune problems have worsened- fibromyalgia pain, migratory glossidis, type 1 diabetesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Survey response — day 28, dose 2MedDRA: Condition aggravated, Eye haemorrhage, Fatigue, Headache, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Blood vessel burst in retina, fatigue, worsened fibromyalgia and background headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-20
-
2021-07-16
Survey response — 3 months, dose 2MedDRA: Condition aggravated, Oedema peripheral, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Increased fibromyalgia flare ups, edema in my legs, dramatic worsening from background to advanced diabetic retinopathyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Moderna | |
| 2 | 2021-04-15 | Moderna |
Call center
2 call center cases
2 unsuccessful
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Light headed and feeling like I'm speaking and moving slowly
Release 6 — day 14, dose 1
Symptoms: Body aches, headaches, chills, injectionsite soreness, worsening pre-existing autoimmune symptoms (fibromyalgia, alopecia, migratory glossidis)
Release 8 — day 21, dose 2
Symptoms: Underlying autoimmune problems have worsened- fibromyalgia pain, migratory glossidis, type 1 diabetes
Release 8 — day 28, dose 2
Symptoms: Blood vessel burst in retina, fatigue, worsened fibromyalgia and background headaches
Release 9 — 3 months, dose 2
Symptoms: Increased fibromyalgia flare ups, edema in my legs, dramatic worsening from background to advanced diabetic retinopathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Eye haemorrhage | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Oedema peripheral | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Bradykinesia | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Slow speech | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release